Read More Pharma Industry News Milestone Pharmaceuticals (NASDAQ: MIST) gets FDA green light for etripamil nasal spray Discover how Milestone Pharmaceuticals’ FDA approval of CARDAMYST (etripamil) is reshaping PSVT treatment and setting the stage for broader cardiovascular care. Read more. bySrinathDecember 15, 2025